(Q48912689)

16 February 2018

title

Platelet GSK3B activity in patients with late-life depression: marker of depressive episode severity and cognitive impairment? (English)

1 reference

16 February 2018

main subject

cognitive dysfunction

1 reference

1

1 reference

16 February 2018

Wagner Farid Gattaz

5

object named as

Wagner Farid Gattaz

1 reference

16 February 2018

author name string

Leda Leme Talib

2

1 reference

16 February 2018

Helena Passarelli Giroud Joaquim

3

1 reference

16 February 2018

Vanessa Rodrigues Jesus de Paula

4

1 reference

16 February 2018

Orestes Vicente Forlenza

6

1 reference

16 February 2018

publication date

11 February 2011

1 reference

16 February 2018

World Journal of Biological Psychiatry

published in

1 reference

16 February 2018

volume

12

1 reference

16 February 2018

issue

3

1 reference

16 February 2018

page(s)

216-222

1 reference

16 February 2018

Association between BanI genotype and increased phospholipase A2 activity in schizophrenia

cites work

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.551408

Regulation of glycogen synthase kinase 3 in human platelets: a possible role in platelet function?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.551408

Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.551408

Mild cognitive impairment: cognitive screening or neuropsychological assessment?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.551408

Serum brain-derived neurotrophic factor level is reduced in antidepressant-free patients with late-life depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.551408

Interleukin-1beta serum levels is increased in antidepressant-free elderly depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.551408

Increased soluble TNF receptor 2 in antidepressant-free patients with late-life depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.551408

Glycogen Synthase Kinase-2 and Phosphorylase Kinase Are the Same Enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.551408

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.551408

Increased platelet GSK3B activity in patients with mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.551408

Clinical and biological predictors of Alzheimer's disease in patients with amnestic mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.551408

Platelet phospholipase A(2) activity in Alzheimer's disease and mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.551408

AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.551408

The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.551408

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.551408

Insulin down-regulates insulin receptor substrate-2 expression through the phosphatidylinositol 3-kinase/Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.551408

Glycogen synthase kinase-3 is increased in white cells early in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.551408

The glamour and gloom of glycogen synthase kinase-3

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.551408

Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.551408

Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.551408

Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on beta-catenin in mouse hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.551408

Alteration in kinase activity but not in protein levels of protein kinase B and glycogen synthase kinase-3beta in ventral prefrontal cortex of depressed suicide victims

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.551408

A molecular mechanism for the effect of lithium on development

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.551408

AKT signaling within the ventral tegmental area regulates cellular and behavioral responses to stressful stimuli.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.551408

Glucocorticoid prevents brain-derived neurotrophic factor-mediated maturation of synaptic function in developing hippocampal neurons through reduction in the activity of mitogen-activated protein kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.551408

Platelet 5-HT2A receptor binding and tryptophan availability in depression are not associated with recent history of suicide attempts but with personality traits characteristic for suicidal behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.551408

In vivo regulation of glycogen synthase kinase-3beta (GSK3beta) by serotonergic activity in mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.551408

Lithium regulates glycogen synthase kinase-3beta in human peripheral blood mononuclear cells: implication in the treatment of bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.551408

Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.551408

BDNF-mediated signal transduction is modulated by GSK3beta and mood stabilizing agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.551408

CAMcog as a screening tool for diagnosis of mild cognitive impairment and dementia in a Brazilian clinical sample of moderate to high education.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.551408

Insulin resistance and depressive symptoms in middle-aged and elderly Chinese: findings from the Nutrition and Health of Aging Population in China Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.551408

Transgenic mice overexpressing glycogen synthase kinase 3beta: a putative model of hyperactivity and mania.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.551408

CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.551408

Glycogen Synthase from Rabbit Skeletal Muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.551408

Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2010.551408

10.3109/15622975.2010.551408

21 January 2018

Identifiers

DOI

1 reference

16 February 2018

1 reference

16 February 2018